Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing facilities in Gebze to Generica İlaç, a Turkish company engaged in the manufacturing, marketing and sale of pharmaceutical products since 2007. The transaction includes the transfer of all associated assets and employees of Sandoz Turkey on the Gebze site. The deal is expected to close by mid-2020 subject to obtaining the necessary approvals from regulatory authorities, including the Competition Board, the Gebze Plastic Manufacturers Organized Industrial Zone and the Ministry of Industry and Technology. After closing, Generica İlaç will continue to manufacture and supply certain products to Novartis.
Paksoy is pleased to announce that Elvan Aziz (partner), Nazlı Bezirci (counsel) and Gözde Zorlu (associate) are advising Novartis on this transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 March 2026
Paksoy advises on Türkiye Petrolleri’s landmark USD 4 billion Sukuk Programme and inaugural USD 1 billion issuance
Paksoy is pleased to have advised on the establishment of Türkiye Petrolleri’s USD 4 billion Sukuk Issuance Programme and the successful…
27 February 2026
International Women’s Day 2026 – Women at Paksoy
At Paksoy, we believe women are fundamental to our leadership and value creation. Their contribution is not just part of our identity - it…
23 February 2026
Doğuhan Uygun and Pınar Noberi contributed to the Austrian Yearbook on International Arbitration 2026
We are pleased to announce that Doğuhan Uygun, partner, and Pınar Noberi, associate, have contributed to the Austrian Yearbook on…
18 February 2026
Once again, we are recognised among the top-tier in the Chambers Global Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers Global Guide 2026.
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.